Paper Details 
Original Abstract of the Article :
AIM: To evaluate various adverse symptoms during short-term use of ulipristal acetate in women with uterine myomas (n = 90), adenomyosis (n = 3) or both (n = 7). METHODS: One hundred premenopausal women who received ulipristal acetate for 4-12 weeks during 2016 to 2017 were selected. The medical re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jog.13917

データ提供:米国国立医学図書館(NLM)

Navigating the Side Effects of Ulipristal Acetate

Ulipristal acetate is a medication used to treat uterine fibroids and adenomyosis, but like many medications, it can have side effects. This study investigates the various adverse symptoms that may occur during short-term use of ulipristal acetate.

Researchers sought to understand the potential risks associated with ulipristal acetate, providing valuable information for patients and healthcare providers. It's like a camel caravan carefully considering the potential dangers of a new route through the desert, seeking to minimize risks and maximize safety.

Understanding the Potential Risks

The study found that adverse symptoms were common during short-term use of ulipristal acetate, with amenorrhea being the most frequent. Other common side effects included weight gain, fatigue, abdominal discomfort, and dizziness. This information is crucial for patients to make informed decisions about treatment options, balancing the potential benefits of ulipristal acetate with the risks of side effects.

Making Informed Decisions

This research highlights the importance of open communication between patients and healthcare providers about potential side effects. Just as a camel caravan relies on its leader to guide it through the desert, patients need to have open communication with their doctors about any concerns or questions they may have regarding their medication.

Dr.Camel's Conclusion

This study delves into the potential side effects of ulipristal acetate, a medication often used to treat uterine fibroids and adenomyosis. It's a reminder that even medications that provide significant benefits can come with potential risks. This research underscores the importance of open communication between patients and healthcare providers, ensuring that patients make informed decisions about treatment options, weighing the potential benefits against the risks of side effects.

Date :
  1. Date Completed 2019-08-14
  2. Date Revised 2019-08-14
Further Info :

Pubmed ID

30675965

DOI: Digital Object Identifier

10.1111/jog.13917

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.